Trial Condition(s):

Hyperphosphatemia

Long-term study in Chronic Kidney Disease (Extension from Study 14817)

Bayer Identifier:

15074

ClinicalTrials.gov Identifier:

NCT01187628

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

The objective of this study is to investigate the safety and the effect on reduction of serum phosphate of long-term administration of lanthanum carbonate (BAY77-1931) 750 to 2250 mg in patients with hyperphosphatemia who completed the 8 week double-blind treatment period of Study 14817 and are judged to be eligible for the long-term extension study.

Inclusion Criteria
- Patients who have completed the 8-week double-blind treatment period of Study 14817 and are judged to be eligible for the long-term extension study by the investigator (including those who plan to be on dialysis during the long-term extension study).
Exclusion Criteria
- Patients with any other conditions that the investigator defines as not appropriate to be enrolled in the study

Trial Summary

Enrollment Goal
123
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Fosrenol (Lanthanum Carbonate, BAY77-1931)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Locations
Locations

Wakayama Medical University Hospital

Wakayama, Japan, 641-8510

Locations

Osaka General Medical Center

Osaka, Japan, 558-8558

Locations

Osaka Rosai Hospital

Sakai, Japan, 591-8025

Locations

Osaka Saiseikai Nakatsu Hospital

Osaka, Japan, 530-0012

Locations

Kitano Hospital

Osaka, Japan, 530-8480

Locations

Okayama Saiseikai General Hospital

Okayama, Japan, 700-0013

Locations

Kurashiki Central Hospital

Kurashiki, Japan, 710-8602

Locations

The Jikei University Hospital

Minato-ku, Japan, 105-8471

Locations

Chubu Rosai Hospital

Nagoya, Japan, 455-8530

Locations

Juntendo Tokyo Koto Geriatric Medical Center

Koto, Japan, 136-0075

Locations

Fujisawa City Hospital

Fujisawa, Japan, 251-8550

Locations

Narita Memorial Hospital

Toyohashi, Japan, 441-8021

Locations

Kawashima Hospital

Tokushima, Japan, 770-0011

Locations

Osaka City General Hospital

Osaka, Japan, 534-0021

Locations

NTT Medical Center Tokyo

Shinagawa, Japan, 141-8625

Locations

Musashino Red Cross Hospital

Musashino, Japan, 180-8610

Locations

Shonan Kamakura General Hospital

Kamakura, Japan, 247-8533

Locations

Kameda Clinic

Kamogawa, Japan, 296-0041

Locations

Kainan Hospital

Yatomi, Japan, 498-8502

Locations

Nagoya Daini Red Cross Hospital

Nagoya, Japan, 466-8650

Locations

Kyushu Medical Center

Fukuoka, Japan, 810-8563

Locations

Kyoto Medical Center

Kyoto, Japan, 612-8555

Locations

Beppu Medical Center

Beppu, Japan, 874-0011

Locations

Oita Medical Center

Oita, Japan, 870-0263

Locations

Nagoya Medical Center

Nagoya, Japan, 460-0001

Locations

Tokyo Medical Center

Meguro-ku, Japan, 152-8902

Locations

Shizuoka Tokushukai Hospital

Shizuoka, Japan, 421-0193

Locations

Social Insurance Chukyo Hospital

Nagoya, Japan, 457-8510

Locations

Tosei General Hospital

Seto, Japan, 489-8642

Locations

Fukuoka University Hospital

Fukuoka, Japan, 814-0180

Locations

Saga Prefectural Hospital Koseikan

Saga, Japan, 840-0054

Locations

Hokkaido Medical Center

Sapporo, Japan, 063-0005

Locations

Kimitsu Chuo Hospital

Kisarazu, Japan, 292-8535

Locations

Kokura Memorial Hospital

Kitakyushu, Japan, 802-0001

Locations

National Fukuoka-Higashi Medical Center

Koga, Japan, 811-3195

Locations

Hyogo Prefectural Amagasaki Hospital

Amagasaki, Japan, 660-0828

Locations

Saiseikai Yokohamashi Nanbu Hospital

Yokohama, Japan, 234-8503

Locations

Saiseikai Yahata General Hospital

Kitakyushu, Japan, 805-0050

Locations

Yokohama City Minato Red Cross Hospital

Yokohama, Japan, 231-8682

Locations

Anjo Kosei Hospital

Anjo, Japan, 446-8602

Trial Design